Theon International Plc will host a follow-up webcast session via the Investor Meet Company platform on Thursday, 09 July 2026, at 11:00am UK-time / 1:00pm Eastern European-time. The session aims to engage with existing and potential investors ahead of the upcoming Q2 results announcement on 27 July 2026, after market close. The webcast will provide an update on recent developments, financial profile, business dynamics, guidance, and strategic initiatives, including the recent agreement to acquire SAS Stéropès, the holding company of SAS HGH Systèmes Infrarouges (HGH), for an enterprise value of approximately €300 million.

The webcast will be hosted by Philipe Mennicken, Deputy CEO and Business Development Director, and Dimitris Parthenis, CFO of Theon International Plc. They will discuss the company's strategic developments and recap its guidance and targets. The session will feature a live Q&A and is open to all existing and potential investors as well as wider market participants.

Investors can sign up for the Investor Meet Company platform for free to attend the event. Those already following Theon International Plc on the platform will automatically receive an invitation. Questions can be submitted ahead of the event via the platform dashboard until 9:00am UK-time / 11:00am Eastern European-time on 09 July 2026, or during the live session.

Key Event Details

Theon International Plc develops and manufactures night vision and thermal imaging systems for defense and security applications. The company has been listed on Euronext Amsterdam (AMS: THEON) since February 2024. In 2025, Theon Group won a procurement tender for over 100,000 Night Vision Goggles for the Belgian and German Armed Forces, valued at approximately €1 billion.

THEON International Plc announced total new order intake of approximately €70 million on June 22, 2026, strengthening its position in the defense sector. A significant portion of this intake comes from Rheinmetall for the Bundeswehr’s Future Soldier program (Infanterist der Zukunft - IdZ), comprising a new firm order and exercised options for products from its A.R.M.E.D ecosystem portfolio. This development underscores THEON’s ambition to lead in Augmented Reality (AR) applications for soldiers, with potential for additional orders later in the year through further exercised options.

Order intake accelerated in the second quarter, reaching approximately €153 million with an additional €27 million in options. This brings total year-to-date order intake to around €223 million, alongside a further €68 million in options. These figures include the full consolidation of Kappa and Harder Digital order intake. THEON anticipates further acceleration in the second half of the year, particularly towards the end of Q4, aligning with typical business seasonality. The company reiterated its guidance of maintaining an organic book-to-bill ratio above 1.0x for FY 2026.

Philippe Mennicken, Deputy CEO and Business Development Director of THEON, stated that the new orders showcase customers’ conviction in THEON’s innovative capabilities and reflect strong trust in its technological expertise and execution capabilities.

Strategic Acceleration

THEON has advanced its entry into drone technologies through a Memorandum of Understanding (MoU) with Safran to form a joint venture (JV). The JV will be 51% controlled by THEON and 49% by Safran, with equal 50/50 governance rights. The CEO role will rotate between the two companies every three years, with the first appointment held by THEON. Part of the JV’s activities will be based in Greece to maintain the Group’s operational base and low-cost competitive advantage.

Additionally, THEON entered an initial agreement to acquire HGH Systèmes Infrarouges (HGH) for an enterprise value of approximately €300 million, marking its entry into counter drone systems. HGH’s AI software is expected to generate synergies across THEON’s platform-based products and man-portable systems. The acquisition is expected to be entirely debt-funded, with leverage reaching a pro-forma level of approximately 3.0x net-debt to EBITDA before lowering to approximately 2.5x by 2027.

Order Intake Summary

Alongside investments in MERIO and Twin Prime this quarter, these strategic moves continue THEON’s push to broaden its capabilities in platform-based products and diversify revenue streams.